Management of Patients Not Receiving Fludrocortisone
All patients with confirmed aldosterone deficiency (primary adrenal insufficiency) must receive mineralocorticoid replacement with fludrocortisone 1.
When Fludrocortisone is Mandatory
If your patient has primary adrenal insufficiency (PAI) and is not receiving fludrocortisone, you need to initiate it immediately. The Endocrine Society guidelines provide strong (Grade 1) recommendations that mineralocorticoid replacement is essential for all patients with confirmed aldosterone deficiency 1.
Initiation Protocol
- Starting dose: 50-100 mcg daily in adults, taken once in the morning 1
- Typical maintenance range: 50-200 mcg daily 1
- Counsel patients: Do not restrict salt intake 1
Special Dosing Considerations
- Children and newborns: Require higher doses due to lower mineralocorticoid sensitivity 1
- Hot climates/excessive sweating: Temporary dose increases of 50-100% or increased salt intake 1
- Prednisolone users: May need more fludrocortisone than hydrocortisone users (prednisolone has less mineralocorticoid activity) 1
- Dexamethasone users: Require fludrocortisone as dexamethasone has no mineralocorticoid activity 1
When Fludrocortisone May Not Be Needed
Secondary adrenal insufficiency patients typically do NOT require fludrocortisone because aldosterone production remains intact (the renin-angiotensin-aldosterone system is independent of pituitary ACTH) 1.
Monitoring Strategy
Monitor replacement primarily through clinical assessment 1:
Clinical Parameters to Assess
- Salt craving (suggests under-replacement)
- Postural hypotension (measure sitting and standing BP; suggests under-replacement)
- Peripheral edema (suggests over-replacement, though low sensitivity)
- General well-being
Laboratory Monitoring
- Serum electrolytes: Target normal range 1
- Plasma renin activity: Upper reference range indicates appropriate dosing 1
- Blood pressure: Both sitting and standing 1
Critical Pitfalls to Avoid
Drug Interactions
- Licorice and grapefruit juice: Potentiate mineralocorticoid effects—patients must avoid these 1
- Phenytoin: Increases fludrocortisone metabolism, requiring higher doses 1
- Potassium-depleting diuretics: Enhanced hypokalemia risk—monitor potassium frequently 2
- Digitalis: Increased arrhythmia risk with hypokalemia—monitor closely 2
Managing Hypertension on Fludrocortisone
If hypertension develops 1:
- First: Reduce fludrocortisone dose
- Second: Evaluate glucocorticoid dose (over-replacement with either can cause hypertension)
- Third: If hypertension persists after adjustment and patient is euvolemic, initiate antihypertensive therapy (ACE inhibitors or ARBs preferred) while continuing fludrocortisone 1
Acute Adrenal Crisis Management
During adrenal crisis with high-dose hydrocortisone (≥100 mg), fludrocortisone is not required acutely because high-dose hydrocortisone provides sufficient mineralocorticoid activity 3. Resume fludrocortisone 0.05-0.1 mg daily once transitioning to maintenance therapy 3.
Tolerance Issues in Elderly Patients
Important caveat: Fludrocortisone is poorly tolerated long-term in older patients with orthostatic hypotension (33% discontinuation rate at mean 5 months) 4. Common reasons for discontinuation include hypertension, cardiac failure, edema, and depression 4. Hypokalaemia develops in 24% of elderly patients 4. This contrasts with its essential role in PAI, where benefits outweigh risks.
Bottom Line Algorithm
Does the patient have primary adrenal insufficiency?
- YES → Start fludrocortisone 50-100 mcg daily immediately + counsel on salt intake
- NO (secondary AI) → Fludrocortisone not indicated
Monitor every visit:
- Orthostatic vital signs
- Salt craving symptoms
- Electrolytes (sodium, potassium)
- Adjust dose based on clinical response and plasma renin activity